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The use and availability of nucleic acid probes are significantly greater than they were three to five years ago. This increased utilization has resulted because of numerous changes in molecular genetic procedures. First, the sources of probes have shifted from cloned genomic and cDNA fragments to single-strand oligonucleotides and RNA or "riboprobes." These newer probes offer defined composition and capability to create separate sense and anti-sense strands. Second, an increased variety of labeling techniques provide more ways to incorporate isotopic and nonisotopic species into these nucleic acid fragments than before. Third, the advent of nucleic acid amplification forecasts the ability to detect sub-attomol quantities of target nucleic acids, which could not be detected by classical hybridization methods. Fourth, more-sensitive signaling systems (e.g., chemiluminescence) now available will also contribute to the lowering of detection limits. Fifth, alternative sample-processing methods will shorten the time required to perform these assays. Finally, coupling these newer molecular probe procedures with automation will lead to improved precision and reliability and promote their introduction into the clinical laboratory as routine procedures. Additional factors such as clinical correlation, cost analysis, etc. will stimulate clinical laboratory personnel to participate further in development and use of these procedures.
The ability of DNA and RNA fragments to detect complementary arrangements of nucleotides in other nucleic acids is seen as a unique property of these compounds. This ability for self-recognition provides an ideal basis for invitro diagnostic testing (1) (2) (3) (4) . In the beginning of nucleic acid-based analysis, this recognition of sequence was exploited for detecting simple changes in primary sequence (e.g., point mutations). Recent advances in molecular genetics have led to the appearance of numerous novel DNAJRNA probe tests such as sandwich assays (5) and target amplification techniques (6, 7) . Since the performance of the first DNA probe tests, our understanding of the organization and function of the gene has undergone considerable development. With these newer probe assays, one can now directly examine not only the transcription product(s) of gene expression, but also the rearrangements of the genes themselves. In the future, our understanding of gene structure (both fine and gross) and their interwoven control mechanisms will likely permit the design and implementation of even more-sophisticated nucleic acid probe tests.
To better appreciate our current capabilities to use nucleic acid probes as diagnostic tools, let us examine the chemistry and interactions of nucleic acid fragments in a more detailed basis: sources of nucleic acid probes, sample processing, labeling methods, analysis formats, hybridiza- 
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Sources of Probes
The sources of nucleic acid probes are illustrated in Figure 1 . During the last 10 years, the emphasis has shifted from probes that were only vaguely characterized (e.g., cloned DNA or RNA fragments) to ones that are precisely defined in terms of size and nucleotide sequence, e.g., single-stranded (ss) DNA, and those that can be created in both sense and anti-sense forms (RNA or "ribo-probes").1 DNA probes derived from genomic material have not been completely replaced by oligonucleotides; rather, their ultimate utility decreases with time because of their less-specific nature. However, genomic probes will remain useful as screening tools in RFLPs, given that the precise genetic lesion is unknown in most (>90%) of the estimated 2000 hereditary disorders in humans.
As an increasing amount of data on amino acid and nucleotide sequence is accumulating for all species, applications of probes based on primary nucleotide sequence are becoming more attractive.
A major advance in probe evelution has been the development of ssDNA ("oligonucleotide") probes. These short ssDNA fragments can distinguish relatively small (one-to two-base) differences between two or more similar targets. Indeed, this ability to selectively hybridize to apparently similar sequences that differ by just one or two bases in a 20-to 30-nucleotide stretch is the basis for allele specific oligonucleotide probes (ASOs) (8) .
In contrast to double-stranded (ds) DNA probes, oligonucleotide probes are created by chemical means; hence, their base sequence must be known before their synthesis occurs. Sequence information necessary for oligonucleotide synthesis can be obtained either directly from the DNA or RNA target or indirectly from the associated amino acid sequence (Figure 1) , with the corresponding nucleotide sequence being inferred (9). The chief attributes of oligonucleotide probes are their rapid, inexpensive production and excellent stability. Their disadvantages are the requirement for knowledge of the nucleotide sequence and the more rigid and precise regulation for hybridization and washing conditions. Another major advance in probe development is the cRNA or "riboprobe," prepared by transcribing a dsDNA template that has been cloned into a transcription vector. Riboprobes possess several advantages in comparison with other types of probes. First, both sense and anti-sense probes can be prepared, just by transcribing the template in opposite directions. This creates the opportunity for synthesizing, from the same stretch of DNA template, background probes (+, or sense strand) as well as signal probes (-, or anti-sense) with the same length, G:C composition, etc. Next, these cRNA probes can undergo hybridization with either DNA or RNA targets and generally produce hybrid duplexes that are more durable to washing reactions. Finally, those cRNA probes that remain unhybridized after incubation can be removed by digestion with RNase, further reducing background signals that arise from residual probes bound nonspecifically. Riboprobes can be labeled almost as extensively as DNA probes; however, they are subject to degradation by RNases, and additional precautions are required in their handling. organized in tandem, repeated fashion (termed variable number of tandem repeats, VNTRs) (10). Their function is still unclear, but they exist apparently unchanged throughout the human genome. Probes cloned (or prepared) from VNTR sequences can then be used for a type of classification scheme known as DNA "fingerprinting" (11).
Another application of using sequence homology to create probes is found in the ribosomal RNA that is shared by individual species of a bacterial genus. A particular genus (or species) can be reliably identified with cDNA probes specific for the ribosomal RNA of the genus or species ( Table 1) .
The principal focus of probe development thus far has been on identification and detection. Other major characteristics of the gene, however, remain relatively unexplored with regard to diagnostic applications, including regulatory functions (e.g., enhancers and promoters), re. combination events (e.g., rearrangements of immunoglobulin exons), and message processing (e.g., mRNA splicing). All will likely receive additional attention in the future.
Sample Processing
For most analytical schemes involving nucleic acid probes, the amount of sample processing required can vary considerably. For example, if genomic nucleic acid is to be analyzed, some effort is usually necessary to extract and purify it before analysis. A typical sample-processing procedure involves proteolytic digestion of the cells, followed by extraction with organic solvents to remove protein and other cellular constituents. The nucleic acids are then kept in a milieu suitable for analysis or they can be further purified by precipitation with ethanol, reconstituted in aqueous buffer, then analyzed. The major exception to this requirement for extensive processing is analysis by the polymerase chain reaction (PCR). Several investigators have recently reported using PCR with intact cells and obtaining satisfactory results (12, 13). To facilitate use of molecular genetic techniques, alternative procedures that accelerate processing have been developed: (a) elimination of extraction(s) with organic solvents by capturing and purifying DNA on a solid phase (14) and (b) use of a strong chaotropic agents (e.g., guanidine thiocyanate) to disrupt and establish a solution environment suitable for direct hybridization (15).
A second major consideration in processing samples is the difference in abundance of target nucleic acids in samples. Of the nucleic acids suitable for analysis, genomic DNA is usually the easiest to obtain in purified form, primarily because of its abundance and relative stability during processing. As their stability and abundance generally decrease, the following target species are usually more difficult to detect: ribosomal RNA (rRNA), viral DNA, viral RNA, and messenger RNA (mRNA). The problem of low target abundance may be ameliorated with one of the enzymatic amplification techniques, e.g., PCR (6) and Qbeta-replicase (7) . Using PCR, for example, one can detect a variety of different nucleic acids, including DNA created from chromosomal translocation (16), viral RNA (17), and even mRNA (18, 19) with minimal processing (1-4 h). By contrast, one to two days may be needed to process a sample for a classical blotting procedure that also require electrophoresis (e.g., Southern or Northern blotting).
Once samples have been processed, a large variety of diagnostic test formats are possible (1, 20, 21) . In general, formats that worked well to answer questions involving basic cell biology (e.g., Southern blot, Northern blots, RNase protection assay, etc.) are the most labor intensive. This is because some portion of the results is obtained by physically separating the mixture of potential targets on the basis of molecular size (e.g., gel electrophoresis), with the subsequent sequence recognition of particular targets by the probes. By contrast, assays in which the specificity resides completely in the probes (e.g., dotlslot blot procedure, target amplification, etc.), rather than being a function of the procedure, have become more popular for diagnostic purposes, primarily because dotfslot blots can be completed in two to three days. Procedures based on size separation may need up to a week to complete and so are not suitable for high sample throughput or where rapid sample turnaround time is required.
Labeling Techniques
Various methods have been developed to incorporate derivatives and reporter species into nucleic acid probes. These methods generally involve endogenous enzymese.g., DNA and RNA polymerases, polynucleotide kinases, 
Analysis Formats
To be accessible for potential binding and subsequent hybridization of nucleic acid probes, the target species must be single stranded (Figure 2 ). To achieve this prerequisite, the formats of earliest analytical methods centered about an alkaline denaturation of the target species, followed by capillary-mediated transfer of ssDNA or RNA fragments from an agarose gel to a solid-phase support (e.g., Southern and Northern blots, respectively). Alternatively, the targets were converted to single strand by incubating the membrane with alkaline buffer (pH -43), then neutralized. to process standards, samples, and controls is less than one day from sample processing to autoradiography on film for final signal detection (37) . Any blotting procedure, however, still requires considerable labor because it entails the general steps outlined in Table 2 .
Other novel diagnostic formats have been reportedstrand displacement (32), sandwich assays (5), the use of magnetized beads to separate the hybridized probe from unbound probe (Table 1) , and ligase-dependent coupling of oligonucleotide probes to a target strand (38)-but have yet to be extensively commercialized at this time. Analysis protocols that are much more attractive for in-vitro diagnostic use, however, do not depend on a solidphase separation of hybridized from free nucleic acid probe. Instead, the juxtaposition of two probes with different reporter species is the basis for a positive detection reaction. A solution phase hybridization similar to one reported recently (39) offers considerable advantages. First, the need to separate free from bound phase is eliminated. Next, the detection procedure is a sensitive nonisotopic technique (fluorescence), which is also a strong advantage. Finally, there is the inherent specificity associated with oligonucleotides, which can be readily synthesized.
Hybridization Reactions
Hybridization
and stringency are key concepts in the utilization of nucleic acid probes. "Hybridization" refers to the set of cooperative interactions that occur between complementary bases located on opposing strands (Figure Table 2 . Protocol for DNA Analyses
Current protocol
Future protocol 2). Because hydrogen bonds are the key components in these interactions, any factor that modulates or controls H-bond strength can influence the extent of probe:target interaction(s). Table 3 lists these factors and indicates how a change in each will affect corresponding probe:target interactions. Figure 3 illustrates the influence of ionic strength and temperature on the fraction of probe:target hybrids remaining after hybridization.
The Tm value (temperature at which 50% of the duplex is denatured) is lower for the nonspecific probe:targets than for the specific probe:-targets; therefore, the nonspecific duplexes are removed by merely increasing the wash temperature to the hybridization temperature.
Only the specific probe:target species remain after this high-stringency wash. In most cases, the major goal of hybridization is to promote maximum probe:target interaction (20 These two procedures are examples of "open" hybridization techniques, which can detect changes that were unexpected in the target material, whereas "closed" procedures such as ASOs cannot because an ASO probe hybridizes to only one sequence and ignores all others. For the ASO probe procedure to be "open" (i.e., capable of detecting all possible combinations of sequences) would require the target be hybridized to a series of ASO probes, each containing a specific sequence for a given mutation.
Detection Techniques
Methods to identify the probe:target duplex have previously centered around the corresponding detection of various atomic particles and radiation emitted by the radioactive species in the probes. For radioisotopes such as 3H, 32P, and 35S, this meant either quantification by liquid scintillation (44) or the exposure of photographic ifim in autoradiography (45 (44) .
The smallest number of microorganisms that can be directly detected with the current generation of DNA probe procedures is between 10 and i0; that is, the smallest amount of DNA that can be revealed on an autoradiogram is -'100-200 ng. To achieve a lower limit of detection, one can try any of several approaches: either some type of target (6, 7) or signal (32,46-48) amplification must occur, or more-sensitive detection reactions such as fluorescence or chemiluminescence (32) will be needed. PCR has already demonstrated its ability to detect single-copy targets (49); other procedures will probably do so in the future.
Quantitative measurements of nucleic acid hybridization by use of several isotopes have been described (Table 1) . Efforts to quantify the PCR reaction, by incorporating either radiolabeled nucleotides or radiolabeled amplimers, have also been described (50). Alternatively, several nonisotopic procedures reportedly yield a quantifiable response that is proportional to the presence of the target species (32, 51). Curiously, both exploit luminescence as the quantifiable property. Although only one commercialized procedure currently utilizes chemiluminescence (Table 1) , others can be expected to follow as chemiluminescence is further developed (52).
Novel applications of molecular biology that provide more diagnostic information are increasingly likely to become utilized more and more in the clinical laboratory. Although some of the earliest tests such as direct hybridization assays are now being converted to nomsotopic formats, more recent applications such as DSP procedures (42, 43) and the amplification procedures for detection of infectious agents (e.g., human immunedeficiency virus, cytomegalovirus, hepatitis B virus, etc.) continue to involve use of radioisotopes.
A robotic instrument designed to automate the Southern blot process, starting with digested DNA samples, also depends on radioisotopes for detection and reconstruction of the autoradiogram (53) .
It therefore appears that several frontiers remain to be mastered before molecular probe technology is used on a large-scale, routine basis: replacement of radioisotopes with more sensitive nonisotopic detection techniques; reduction of labor investment, with parallel decrease in turnaround time; increased demonstration of clinical significance for probe results; development of quality-assurance programs; and assessment of costibenefit ratio for these tests. Automation can be expected to solve some of these problems (i.e., sample handling, analysis and signal detection, reliability, and reproducibility), but the remaining ones will need to be addressed by the clinical laboratory. Training and subsequent involvement of knowledgeable laboratory personnel will also be of paramount importance to the increased utilization of this exciting technology.
